Guides
B12 Levels: The 180, 200 and 350 Cut-offs and Deficiency Symptoms
B12 below 180 pg/mL means deficiency; 180–350 is indeterminate (NICE 2024); the Turkish Society of Hematology (THD) takes below 200 as the lower limit. Read which symptoms mean you should seek care without waiting.
Translated from the Turkish original by Doktorclub. The Turkish version is the reference text; this English translation has not been separately reviewed by a physician. Read the Turkish original.

Key takeaway
Vitamin B12 is needed for the nervous system and for making blood. According to the 2024 NG239 guideline of England's National Institute for Health and Care Excellence (NICE), deficiency is considered confirmed if total B12 is below 180 ng/L. Between 180 and 350 ng/L is the indeterminate zone; above 350 ng/L deficiency is unlikely. The 2025 guideline of the Turkish Society of Hematology (THD) also gives below 200 pg/mL as the widely accepted lower limit. When interpreting, the laboratory reference range on your report applies.
Short Answer
If total B12 is below 180 ng/L (pg/mL), deficiency is confirmed. Between 180 and 350 the result is indeterminate; if there are symptoms, a further test is needed (NICE 2024).
Common symptoms are tiredness, forgetfulness, numbness in the hands and feet, and balance problems (NICE 2024). Above 350 ng/L, deficiency is unlikely. The Turkish Society of Hematology (THD 2025), for its part, gives below 200 pg/mL as the widely used lower limit. If your report says pg/mL, the number is the same as in ng/L.
This page explains the symptoms and causes of deficiency and the path to diagnosis. The question of injection or tablet is answered on a separate page: Who needs B12 injections?
B12 deficiency symptoms: which ones matter?
B12 deficiency develops slowly. Symptoms start vaguely and are often put down to other causes. England's NICE NG239 guideline (2024) lists these symptoms as common:
- Unexplained tiredness
- Difficulty concentrating, short-term forgetfulness ("brain fog")
- Tingling and numbness in the hands and feet
- Balance problems, walking difficulty, falls
- Redness and soreness of the tongue (glossitis)
- Blurred vision or loss of visual field related to the optic nerve
- Anemia or large red blood cells (macrocytosis) on a blood count
- Anemia in pregnancy or breastfeeding that does not respond to iron treatment
NICE states that depression, anxiety and psychosis may also be linked to deficiency. According to THD 2025, nerve and mental findings can appear before blood values become abnormal. The most important early nerve finding is reduced vibration and position sense in the legs.
The absence of anemia does not rule out B12 deficiency (NICE 2024). Even if your hemoglobin is normal, numbness or a balance problem is taken seriously. For other causes of numbness, see the numbness and tingling guide.
Seek care without waiting
- Rapidly increasing numbness, loss of strength in the legs, being unable to walk or frequent falls: go to the emergency department the same day.
- Sudden confusion, or seeing or hearing things that are not real: go to the emergency department.
- Sudden loss of vision: go to the emergency department without waiting.
- Numbness or weakness after using laughing gas: seek care without waiting.
- Chest pain, shortness of breath at rest or fainting: this may be severe anemia; call 112 (in Türkiye) or your local emergency number.
According to NICE, if there are nerve symptoms together with anemia, treatment does not wait for the test result. The blood sample is still taken before treatment.
What does my B12 result mean? Threshold table
NICE NG239 (March 2024) divides the first test into three zones. Active B12 (holotranscobalamin) is the part of B12 that cells can use. Some laboratories run it as a separate test.
| Total B12 | Active B12 | Meaning | Usual next step |
|---|---|---|---|
| Below 180 ng/L (133 pmol/L) | Below 25 pmol/L | Deficiency confirmed | The cause is investigated and treatment is planned. |
| 180–350 ng/L (133–258 pmol/L) | 25–70 pmol/L | Indeterminate; deficiency is possible | If there are symptoms, a methylmalonic acid (MMA) test is considered. |
| Above 350 ng/L (258 pmol/L) | Above 70 pmol/L | Deficiency unlikely | Other causes of the symptoms are investigated. If symptoms last 3–6 months, the test can be repeated. |
| High without taking supplements | – | Not deficiency; a separate finding | Discuss the result with your doctor. |
When does treatment start without waiting in the indeterminate zone? NICE recommends treatment without waiting for the MMA result in these situations (recommendation 1.3.14):
- A condition that could worsen rapidly: loss of balance (ataxia) or anemia.
- Suspicion of a permanent cause such as autoimmune gastritis.
- Removal of the stomach, removal of the end of the small intestine, or some obesity operations.
- Pregnancy or breastfeeding.
If there are no symptoms and the result is indeterminate, NICE recommends seeking care when symptoms appear. Targets such as "ideal B12 should be 500" have no basis in guidelines.
How it looks on your report
The test is listed as "Vitamin B12", "B12 (Serum)" or "Kobalamin" (cobalamin). In the Ministry of Health of Türkiye unit standard, the unit is ng/L. On a report that says pg/mL the number is the same. Reports from abroad may show pmol/L.
Example line: Vitamin B12 … 240 ng/L. In a laboratory whose lower limit is 200, this result appears within range. According to NICE, however, it is in the indeterminate zone. If you have numbness in your feet and have used a stomach-protecting medicine for years, this result may call for a further test. If you have no complaints at all, the same number is not a reason for treatment on its own.
Two guidelines, two numbers
| Source | Threshold | How is it used? |
|---|---|---|
| NICE 2024 (England) | Below 180 confirmed, 180–350 indeterminate | Read together with symptoms and risk factors. In the indeterminate zone, MMA or active B12 is requested. |
| THD 2025 (Türkiye) | Below 200 pg/mL is the widely used lower limit | The Turkish guideline notes that active B12 is not yet widely available. |
| Your laboratory | The reference range written on the report | NICE allows locally validated thresholds where there are differences between laboratories. |
NICE also notes that the B12 reference range may be higher in people of Black ethnic origin.
Who needs testing?
NICE recommends the test for people who have at least one common symptom together with at least one risk factor. If there is only a symptom, the decision is the doctor's. Testing "just as a check" when there are no symptoms and no risk is not part of the guideline. A result in the indeterminate zone can lead to unnecessary worry and supplement use.
| Risk group | Examples (NICE 2024) |
|---|---|
| Medicines | Metformin; medicines that reduce stomach acid (proton pump inhibitors, H2 blockers); colchicine, phenobarbital, pregabalin, primidone, topiramate |
| Stomach and bowel | Atrophic gastritis affecting the body of the stomach, celiac disease, stomach or small intestine surgery, most obesity operations |
| Diet | A vegan diet or a diet that excludes animal foods; egg, milk or fish allergy; difficulty preparing food (dementia, frailty, mental health problems); low income; eating disorder |
| Other | Family history of B12 deficiency or autoimmune disease; thyroid disease, Sjögren's syndrome, type 1 diabetes; radiotherapy to the abdomen or pelvis; recreational laughing gas |
According to NICE, in a person whose stomach has been completely removed or whose last part of the small intestine has been completely removed, deficiency is very likely if there is no B12 replacement.
Why does B12 run low?
B12 in food is bound to protein. It is released in the stomach by acid and pepsin. It then binds to intrinsic factor, which is secreted by the stomach. It is absorbed from the last part of the small intestine (THD 2025). Every link in the chain can fail:
- Medicines: Metformin and long-term stomach acid suppressants are the most common examples. Long-term metformin use is associated with B12 deficiency (Aroda 2016). THD 2025 requires that metformin always be asked about when B12 deficiency is investigated. For monitoring, see the metformin and B12 guide.
- Autoimmune gastritis: In Türkiye it is most often known as "pernicious anemia". The immune system targets the stomach cells that produce acid and intrinsic factor.
- Low intake: The natural sources of B12 are animal foods. According to THD 2025, liver, red meat and fish are rich in it; it is also found in milk and eggs. Plant foods do not naturally contain B12; breakfast cereals with added B12 and nutritional yeast can be sources (NIH ODS). A person on a vegan or strict vegetarian diet should take a supplement (THD 2025).
- Operations: Most stomach-reduction operations are in this group. See vitamin deficiency after obesity surgery.
- Laughing gas: Recreational use can cause severe nerve damage. In this situation NICE recommends homocysteine or MMA as the first test.
- Babies: According to THD 2025, the most common cause in infants in Türkiye is the mother's B12 deficiency during pregnancy.
How much is needed per day? The Türkiye Dietary Guidelines (TÜBER 2022) give 4.0 µg for adult women, 4.5 µg in pregnancy and 5.0 µg when breastfeeding. In the USA, adult values are 2.4–2.8 µg (NIH ODS). These numbers are for healthy people; they are not to be confused with treatment doses.
The path to diagnosis: which test comes next?
- First assessment: Family physician or Internal Medicine. A complete blood count, folate and ferritin are requested together with B12. Blood is taken before treatment.
- Indeterminate result: If there are symptoms, MMA may be requested. MMA can also rise in kidney failure and in older age (NIH ODS). Active B12 is not run in every laboratory; you may need to ask. The procedure list of the Social Security Institution (SGK) includes the serum MMA test; there is no separate item for active B12. SGK pays for the homocysteine test only if it is requested by certain specialists such as hematology, neurology, endocrinology, and obstetrics and gynecology (SUT Annex 2/B).
- Looking for the cause: If autoimmune gastritis is suspected, an anti-intrinsic factor antibody test is requested. According to NICE, a negative result does not rule out the disease. If no cause is found, a celiac test is recommended.
- Referral: Gastroenterology if endoscopy is needed, Neurology for numbness or walking difficulty, Hematology for severe anemia.
| Finding | What does it suggest? | Source |
|---|---|---|
| Low B12 + low folate | Combined deficiency. Folic acid alone is not started before the B12 status is clear. | THD 2025 |
| Low B12 + high MCV + low hemoglobin | Megaloblastic anemia. A blood count alone does not make the diagnosis. | THD 2025 |
| Low B12 + normal MCV | Accompanying iron deficiency or thalassemia trait can make the MCV look normal. Ferritin is also requested. | THD 2025 |
| Indeterminate B12 + high MMA | The likelihood of deficiency increases; kidney function is also taken into account. | NICE 2024, NIH ODS |
| High homocysteine | Supports B12 deficiency. Folate deficiency, kidney function and some medicines also raise it. | NICE 2024 |
Details: low folate, high homocysteine, how to read a complete blood count, ferritin.
Things that distort the result
- Supplements and injections: An over-the-counter tablet, injection or patch raises the blood level. It can mask the deficiency without fully correcting it (NICE 2024). Say what you are using.
- Combined contraceptive pill: It can lower total B12 without there being a deficiency. A low result can still be a real deficiency (NICE 2024).
- Biotin: On some analyzers, high-dose biotin can make the result misleading. See does biotin distort test results?
- Time of day: The Ministry of Health guide recommends that blood for routine tests preferably be given in the morning between 07:00 and 09:00.
Treatment and follow-up schedule
The route of treatment is chosen according to the cause; your doctor sets the dose and frequency. In brief, the NICE 2024 framework is as follows:
- Lifelong intramuscular B12 in autoimmune gastritis, or after complete removal of the stomach or complete removal of the end of the small intestine.
- Mostly oral B12 in deficiency due to diet.
- Injection or tablet in deficiency due to a medicine; continued for as long as the medicine continues.
For the decision table by cause, the types of ampoule in Türkiye and the evidence for tablets: B12 injection or tablet?
Does SGK pay? 1,000 µg B12 ampoules are prescription medicines and are on SGK's reimbursement list. On the list, oral B12 appears only as a combination tablet together with B1 and B6. You mostly pay yourself for a tablet that contains B12 alone (SUT Annex 4/A, October 2026).
| Time | What happens, what is done? | Source |
|---|---|---|
| First 48 hours | In severe deficiency, potassium can fall seriously; the patient is monitored closely. | THD 2025 |
| Day 7–10 | A blood test commonly done in England to see that the treatment is working. | NHS |
| Week 2 to month 3 | Symptoms start to improve; it may take longer for them to go away completely. | NICE 2024 |
| Around week 8 | In England a second blood test may be done to confirm that the treatment has been successful. | NHS |
| Month 3 (month 1 in pregnancy and breastfeeding) | First follow-up visit. | NICE 2024 |
| After treatment has ended | A check once a year in adults; more often in babies and in those with an underlying disease. | THD 2025 |
In severe deficiency, if marked muscle weakness or palpitations occur in the first days, go to the emergency department the same day. According to the Ministry of Health's 2024 rational test-ordering list, in outpatient visits the B12 test is not repeated before 180 days without a justification. The doctor can request it earlier by writing a justification such as "monitoring of treatment".
Common mistakes
- "My hemoglobin is normal, so B12 is not a problem." Wrong. Nerve findings can start before anemia.
- "I took a supplement first, then had the test, and it came back normal." A supplement raises the blood level and can mask the deficiency. Have the test before treatment.
- "My B12 is low, so I'll take folic acid as well." In B12 deficiency, folic acid alone can worsen nerve findings (THD 2025).
- "I'm in the indeterminate zone, so I'll get an injection." If there are no symptoms and no risk, a doctor's assessment is needed first. An injection given before the test delays finding the cause.
- "I'm not vegan, so the deficiency can't be from diet." Wrong. NICE also counts an older person who has difficulty preparing food, or a person on a low income, as at risk of low intake. The reverse is also true: in a vegan person, diet may not be the only cause.
Special groups
- Pregnancy and breastfeeding: NICE recommends active B12 as the first test in pregnancy. There is no separate test recommendation for breastfeeding. According to THD 2025, this test is not yet widely available; ask your laboratory. If autoimmune gastritis is suspected, NICE recommends that injections start without waiting for the antibody result. According to their product information, the hydroxocobalamin-containing combination ampoules and the 1 mg combination B12 tablets in Türkiye are not used in pregnancy and breastfeeding; choose the product with your doctor.
- Babies and children: According to THD 2025, infants may show growth retardation, loss of acquired skills, tremor and listlessness. The mother of a baby found to be deficient is also investigated. NICE NG239 is for people over 16.
- Older people: B12 should come to mind in unexplained forgetfulness, behavior change or falls.
- Autoimmune gastritis: According to NICE, the risk of gastric neuroendocrine tumor increases; the risk of stomach cancer may also be increased. Referral for endoscopy is considered for new or worsening indigestion, nausea or vomiting.
- People with thyroid disease: Autoimmune thyroid disease is a risk factor. For thyroid tests, see the TSH, T3, T4 and anti-TPO guide.
For a preliminary assessment based on your symptoms and risk factors you can use the deficiency risk test, and to enter your result you can use the lab result interpreter.
What has changed?
- 24 October 2026: Symptoms and emergencies were moved to the top of the page. A table comparing the NICE and THD thresholds, an example report line, a follow-up schedule after treatment and information on SGK payment for medicines and tests were added. The choice between injection and tablet and the topic of excess B12 are covered in the B12 injection guide.
- 23 October 2026: NICE's criteria for treatment without waiting when the result is indeterminate, a risk factor table and the TÜBER 2022 daily requirement values were added.
- The B12 result zones were updated according to NICE NG239 (2024) and the Turkish Society of Hematology 2025 guideline.
Sources added in this update
- NHS. Vitamin B12 or folate deficiency anaemia – Treatment. https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/treatment/ (accessed 24 October 2026)
- Sosyal Güvenlik Kurumu [Social Security Institution, SGK]. Sağlık Uygulama Tebliği Ek-4/A Bedeli Ödenecek İlaçlar Listesi (Resmî Gazete 02.10.2026, sayı 33388 değişikliği işlenmiş) [Health Implementation Communiqué (SUT) Annex 4/A, List of Reimbursed Medicines, incorporating the amendment in Official Gazette of 02.10.2026, No. 33388]. https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed 24 October 2026)
- Sosyal Güvenlik Kurumu [Social Security Institution, SGK]. Sağlık Uygulama Tebliği Ek-2/B Hizmet Başı İşlem Puan Listesi (yürürlük 07.07.2026; 02.10.2026 değişikliği işlenmiş güncel SUT), L105290 metil malonik asit ve L109960 homosistein satırları [Health Implementation Communiqué (SUT) Annex 2/B, Fee-for-Service Procedure Points List (in force 07.07.2026; current SUT incorporating the 02.10.2026 amendment), lines L105290 methylmalonic acid and L109960 homocysteine]. https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed 24 October 2026)
- TİTCK [Turkish Medicines and Medical Devices Agency]. Hidroksokobalamin, B6, B1 ve lidokain içeren kombine IM ampul Kısa Ürün Bilgileri (iki ürün), bölüm 2, 4.2, 4.3 ve 4.6 [Summaries of Product Characteristics of combination IM ampoules containing hydroxocobalamin, B6, B1 and lidocaine (two products), sections 2, 4.2, 4.3 and 4.6]. TİTCK-approved SmPC 1 (PDF); TİTCK-approved SmPC 2 (PDF) (accessed 24 October 2026)
- TİTCK [Turkish Medicines and Medical Devices Agency]. B1, B6 ve B12 vitamini kombine film kaplı tablet (250 mg/250 mg/1 mg) Kısa Ürün Bilgisi, bölüm 2 ve 4.2 [Summary of Product Characteristics of vitamin B1, B6 and B12 combination film-coated tablet (250 mg/250 mg/1 mg), sections 2 and 4.2]. TİTCK-approved SmPC (PDF) (accessed 24 October 2026)
Sources
- National Institute for Health and Care Excellence. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). March 2024. https://www.nice.org.uk/guidance/ng239 (accessed 23 October 2026)
- Türk Hematoloji Derneği [Turkish Society of Hematology, THD]. Eritrosit Hastalıkları ve Hemoglobin Bozuklukları Tanı ve Tedavi Kılavuzu [Guideline for the Diagnosis and Treatment of Red Blood Cell Diseases and Hemoglobin Disorders]. 2025, version 1.4. https://file.thd.org.tr/file/ER%C4%B0TROS%C4%B0T-KILAVUZ-2025-.pdf (accessed 23 October 2026)
- NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. Updated 2 July 2025. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/ (accessed 23 October 2026)
- Aroda VR et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab 2016;101:1754-1761. https://doi.org/10.1210/jc.2015-3754 (accessed 2 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Tıbbi Biyokimya Toplam Test Süreci Rehberi [Medical Biochemistry Total Testing Process Guide]. May 2024, Publication No. 1287. https://dosyamerkez.saglik.gov.tr/Eklenti/48692/0/tibbi-biyokimya-toplam-test-sureci-rehberipdf.pdf (accessed 23 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Test Ölçüm Birimleri, Versiyon 2 [Test Measurement Units, Version 2]. 2021. https://dosyamerkez.saglik.gov.tr/Eklenti/41467/0/test-olcum-birimleri-versiyon-2-pdfpdf.pdf (accessed 2 October 2026)
- T.C. Sağlık Bakanlığı SHGM [Ministry of Health of Türkiye, General Directorate of Health Services]. Karar Sınırı (Eşik Değer), Kritik Değer (Panik Değer) ve Ölçüm Birimlerinin Harmonizasyonu Prosedürü [Procedure for the Harmonization of Decision Limits (Threshold Values), Critical Values (Panic Values) and Measurement Units]. 2020. https://dosyamerkez.saglik.gov.tr/Eklenti/15143/0/karar-siniri-esik-deger-kriek42009846pdf.pdf (accessed 2 October 2026)
- T.C. Sağlık Bakanlığı [Ministry of Health of Türkiye]. e-Nabız Kullanım Kılavuzu V2.1 [e-Nabız User Manual V2.1]. 2025. https://enabiz.gov.tr/document/User_Manual.pdf (accessed 2 October 2026)
- 112 Acil Çağrı Merkezi [112 Emergency Call Center]. Resmî internet sitesi [Official website]. 2026. https://www.112.gov.tr/ (accessed 2 October 2026)
- T.C. Sağlık Bakanlığı HSGM [Ministry of Health of Türkiye, General Directorate of Public Health]. Türkiye Beslenme Rehberi (TÜBER) 2022, Tablo 7.9 [Türkiye Dietary Guidelines (TÜBER) 2022, Table 7.9]. https://hsgm.saglik.gov.tr/depo/birimler/saglikli-beslenme-ve-hareketli-hayat-db/Dokumanlar/Rehberler/Turkiye_Beslenme_Rehber_TUBER_2022_min.pdf (accessed 23 October 2026)
- Sosyal Güvenlik Kurumu [Social Security Institution, SGK]. Sağlık Uygulama Tebliği Ek-4/A Bedeli Ödenecek İlaçlar Listesi (Resmî Gazete 02.10.2026, sayı 33388 değişikliği işlenmiş) [Health Implementation Communiqué (SUT) Annex 4/A, List of Reimbursed Medicines, incorporating the amendment in Official Gazette of 02.10.2026, No. 33388]. https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed 24 October 2026)
- TİTCK [Turkish Medicines and Medical Devices Agency]. Hidroksokobalamin, B6, B1 ve lidokain içeren kombine IM ampul Kısa Ürün Bilgileri (iki ürün), bölüm 2, 4.2, 4.3 ve 4.6 [Summaries of Product Characteristics of combination IM ampoules containing hydroxocobalamin, B6, B1 and lidocaine (two products), sections 2, 4.2, 4.3 and 4.6]. TİTCK-approved SmPC 1 (PDF); TİTCK-approved SmPC 2 (PDF) (accessed 24 October 2026)
- TİTCK [Turkish Medicines and Medical Devices Agency]. B1, B6 ve B12 vitamini kombine film kaplı tablet (250 mg/250 mg/1 mg) Kısa Ürün Bilgisi, bölüm 2 ve 4.2 [Summary of Product Characteristics of vitamin B1, B6 and B12 combination film-coated tablet (250 mg/250 mg/1 mg), sections 2 and 4.2]. TİTCK-approved SmPC (PDF) (accessed 24 October 2026)
- EFSA. Overview on Tolerable Upper Intake Levels as derived by the SCF and the EFSA NDA Panel. https://www.efsa.europa.eu/sites/default/files/2024-05/ul-summary-report.pdf (accessed 23 October 2026)
- NHS. Vitamin B12 or folate deficiency anaemia – Treatment. https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/treatment/ (accessed 24 October 2026)
- Sosyal Güvenlik Kurumu [Social Security Institution, SGK]. Sağlık Uygulama Tebliği Ek-2/B Hizmet Başı İşlem Puan Listesi (yürürlük 07.07.2026; 02.10.2026 değişikliği işlenmiş güncel SUT), L105290 metil malonik asit ve L109960 homosistein satırları [Health Implementation Communiqué (SUT) Annex 2/B, Fee-for-Service Procedure Points List (in force 07.07.2026; current SUT incorporating the 02.10.2026 amendment), lines L105290 methylmalonic acid and L109960 homocysteine]. https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed 24 October 2026)
Frequently asked questions
My B12 came back 240. Is that normal?
It may appear within range for your laboratory, but according to England's NICE 2024 guideline, 180–350 ng/L is the indeterminate zone. If you have a symptom such as numbness and a risk factor such as a stomach-protecting medicine, a further test may be needed. If you have no complaints at all, this number is not a reason for treatment on its own.
Are pg/mL and ng/L the same on a B12 result?
Yes, the number is the same. The Ministry of Health of Türkiye unit standard is ng/L; on a report that says pg/mL the number does not change. Reports from abroad may show pmol/L; 180 ng/L corresponds to 133 pmol/L.
My hemoglobin is normal. Can I still have B12 deficiency?
Yes. The absence of anemia does not rule out B12 deficiency. According to the Turkish Society of Hematology (THD), nerve and mental findings can appear before blood values become abnormal. The most important early nerve finding is reduced vibration and position sense in the legs.
My B12 came back normal but my feet are numb. What should I do?
Look at the number first. If it is above 350 ng/L, deficiency is unlikely according to NICE 2024 and other causes of the numbness are investigated. If it is between 180 and 350, it is in the indeterminate zone even if the laboratory calls it normal; if there are symptoms, a further test such as methylmalonic acid (MMA) may be requested. If the numbness is increasing rapidly, go to the emergency department the same day.
Does the contraceptive pill make B12 look low?
Yes, the combined contraceptive pill can lower total B12 without there being a deficiency. But a low result can still be a real deficiency. Tell your doctor that you are taking the pill; the result is interpreted together with symptoms.
Is folic acid also taken in B12 deficiency?
Do not take it on your own. According to the Turkish Society of Hematology (THD), in B12 deficiency folic acid alone can worsen nerve findings. Even if B12 and folate are both low, folic acid alone is not started before the B12 status is clear. Your doctor plans the treatment.



